AI assistant
GlaxoSmithKline PLC — Director's Dealing 2015
Jul 10, 2015
5262_dirs_2015-07-10_77b862d0-5cd2-4c33-a69a-674b9a9ceb72.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7890S
GlaxoSmithKline PLC
10 July 2015
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 10 July 2015 that the following Directors and Persons Discharging Managerial Responsibilities acquired GSK Ordinary Shares ('Shares') on 9 July 2015, at a price of 1368.97 pence per Share, as a result of the reinvestment of dividends paid on Shares held through GSK's ShareReward Plan (the 'Plan'):
| Director/PDMR | Ordinary Shares |
| Sir Andrew Witty | 40 |
| Mr R G Connor | 50 |
| Mr S Dingemans | 13 |
| Mr S A Hussain | 10 |
| Mr D S Redfern | 57 |
| Ms C Thomas | 57 |
| Mr P C Thomson | 29 |
| Dr P J T Vallance | 33 |
| Ms E Walmsley | 8 |
| Mrs V A Whyte | 40 |
V A Whyte
Company Secretary
10 July 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEBLFFEDFBBBL